These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28302321)

  • 1. Biotin in multiple sclerosis and false biological hyperthyroidism: Mind the interference.
    Willeman T; Casez O; Faure P
    Rev Neurol (Paris); 2017 Mar; 173(3):173-174. PubMed ID: 28302321
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotin Interference in the Measurement of Thyroid Hormone.
    Koehler VF; Mann U; Mann WA
    Dtsch Arztebl Int; 2018 Jul; 115(29-30):500. PubMed ID: 30135010
    [No Abstract]   [Full Text] [Related]  

  • 3. Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis.
    Cusini C; Sassi L; De Paola G; Piantanida E
    J Endocrinol Invest; 2017 Aug; 40(8):889-890. PubMed ID: 28478548
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intake of high dose biotin: A cause of artificial hyperthyroidism].
    Bouillet B; Rouland A
    Rev Med Interne; 2020 Feb; 41(2):123-125. PubMed ID: 31813616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent, but Totally Misleading, Thyroid Function Test Results.
    Marot D; Maquart FX; Delemer B; Decoudier B
    Clin Chem; 2017 Mar; 63(3):788-789. PubMed ID: 28242835
    [No Abstract]   [Full Text] [Related]  

  • 6. High dose biotin as treatment for progressive multiple sclerosis.
    Birnbaum G; Stulc J
    Mult Scler Relat Disord; 2017 Nov; 18():141-143. PubMed ID: 29141796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intersections of pathways involving biotin and iron relative to therapeutic mechanisms for progressive multiple sclerosis.
    Heidker RM; Emerson MR; LeVine SM
    Discov Med; 2016 Dec; 22(123):381-387. PubMed ID: 28147220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A caution regarding high-dose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients.
    Trambas CM; Sikaris KA; Lu ZX
    Med J Aust; 2016 Aug; 205(4):192. PubMed ID: 27510354
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotin induced biochemical hyperthyroidism: a case report and review of the literature.
    James A; Stalan J; Kuzhively J
    J Med Case Rep; 2023 Jun; 17(1):266. PubMed ID: 37370185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences.
    Piketty ML; Polak M; Flechtner I; Gonzales-Briceño L; Souberbielle JC
    Clin Chem Lab Med; 2017 May; 55(6):780-788. PubMed ID: 27732554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoassay interference secondary to therapeutic high-dose biotin: A paediatric case report.
    Evans N; Yates J; Tobin J; McGill J; Huynh T
    J Paediatr Child Health; 2018 May; 54(5):572-575. PubMed ID: 29405469
    [No Abstract]   [Full Text] [Related]  

  • 12. JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.
    Travasarou M; Marousi S; Papageorgiou E; Karageorgiou CE
    Clin Neurol Neurosurg; 2013 Jun; 115(6):827-9. PubMed ID: 22920632
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis.
    Pietropaolo V; Fioriti D; Mischitelli M; Anzivino E; Santini M; Millefiorini E; Di Rezze S; Degener AM
    New Microbiol; 2005 Jul; 28(3):199-203. PubMed ID: 16240691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erroneous thyroid diagnosis due to over-the-counter biotin.
    Charles S; Agrawal N; Blum M
    Nutrition; 2019 Jan; 57():257-258. PubMed ID: 30199718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe transient myopathy in a patient with progressive multiple sclerosis and high-dose biotin.
    Maillart E; Mochel F; Acquaviva C; Maisonobe T; Stankoff B
    Neurology; 2019 May; 92(22):1060-1062. PubMed ID: 31028130
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to letter to the editors.
    Birnbaum G; Stulc J
    Mult Scler Relat Disord; 2018 May; 22():86. PubMed ID: 29626803
    [No Abstract]   [Full Text] [Related]  

  • 17. Natalizumab for relapsing multiple sclerosis.
    Meyer MA
    N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16742009
    [No Abstract]   [Full Text] [Related]  

  • 18. Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis.
    Daniels GH; Vladic A; Brinar V; Zavalishin I; Valente W; Oyuela P; Palmer J; Margolin DH; Hollenstein J
    J Clin Endocrinol Metab; 2014 Jan; 99(1):80-9. PubMed ID: 24170099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus.
    Werner MH; Huang D
    J Neurovirol; 2016 Dec; 22(6):871-875. PubMed ID: 27198748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severity.
    Huppke P; Hummel H; Ellenberger D; Pfeifenbring S; Stark W; Huppke B; Brück W; Gärtner J
    Mult Scler; 2015 Apr; 21(4):382-7. PubMed ID: 25070674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.